Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Recalibrates Office Of Generic Drugs
As Part Of Wider Structural Changes To CDER
Jan 11 2021
•
By
Dave Wallace
The FDA is reorganizing the Office of Generic Drugs • Source: Shutterstock
(Sarah Silbiger/Getty Images)
More from Regulation
More from Policy & Regulation